Hospital or health organisation
Geisinger Neuroscience Institute
Danville, United States · geisinger.org/neuroscience
Part of Geisinger Health System
- Citations, last 5 years
- 1 889
- Works, last 5 years
- 118
- h-index
- 67
- Scientists listed
- 0
- Grants since 2016
- 81
Grants received
2025–2029 · research · R01
Advancing Perinatal Genomic Discoveries through Patient Engagement and Data Sharing
Erin Rooney Riggs · Geisinger Neuroscience Institute · funded by National Institutes of Health
2025–2029 · research · R01
Assessing the relationship between extreme heat and cardiovascular and pulmonary outcomes to identify strategies for health system intervention
Melissa Poulsen · Geisinger Neuroscience Institute · funded by National Institutes of Health
2024–2029 · research · R01
7/7-PsycheMERGE: Advancing Precision Psychiatry
Christopher F. Chabris · Geisinger Neuroscience Institute · funded by National Institutes of Health
2024–2029 · research · R01
Blood Trauma, Vascular Remodeling, and Vasoregulation with Total Body Continuous Versus Pulsatile Artificial Circulation
Carlo R Bartoli · Geisinger Neuroscience Institute · funded by National Institutes of Health
2024–2029 · research · R01
7/7-PsycheMERGE: Advancing Precision Psychiatry
Christopher F. Chabris · Geisinger Neuroscience Institute · funded by National Institutes of Health
2024–2029 · cooperative agreement · U01
Making Genomic Medicine Routine in a Rural Healthcare System
Adam H Buchanan · Geisinger Neuroscience Institute · funded by National Institutes of Health
2024–2029 · research · R01
Blood Trauma, Vascular Remodeling, and Vasoregulation with Total Body Continuous Versus Pulsatile Artificial Circulation
Carlo R Bartoli · Geisinger Neuroscience Institute · funded by National Institutes of Health
2022–2027 · research · R01
Characterizing the spectrum of genomic and phenotypic variation in cerebral palsy
Scott Myers · Geisinger Neuroscience Institute · funded by National Institutes of Health
2022–2027 · research · R01
Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH)
Matthew Oetjens · Geisinger Neuroscience Institute · funded by National Institutes of Health
2022–2027 · research · R33
Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH
Samuel S Gidding · Geisinger Neuroscience Institute · funded by National Institutes of Health
2022–2027 · research · R01
Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH)
Matthew Oetjens · Geisinger Neuroscience Institute · funded by National Institutes of Health
2022–2027 · research · R01
Characterizing the spectrum of genomic and phenotypic variation in cerebral palsy
Andres Moreno De Luca · Geisinger Neuroscience Institute · funded by National Institutes of Health
2022–2027 · research · R33
Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH
Samuel S Gidding · Geisinger Neuroscience Institute · funded by National Institutes of Health
2022–2027 · research · R01
Characterizing the spectrum of genomic and phenotypic variation in cerebral palsy
Scott Myers · Geisinger Neuroscience Institute · funded by National Institutes of Health
2021–2026 · research · R01
Real-time genetic diagnosis at the point of care
Marc S. Williams · Geisinger Neuroscience Institute · funded by National Institutes of Health
2021–2026 · research · R01
Real-time genetic diagnosis at the point of care
Marc S. Williams · Geisinger Neuroscience Institute · funded by National Institutes of Health
2021–2026 · research · R01
Real-time genetic diagnosis at the point of care
Marc S. Williams · Geisinger Neuroscience Institute · funded by National Institutes of Health
2021–2026 · research · R01
Real-time genetic diagnosis at the point of care
Marc S. Williams · Geisinger Neuroscience Institute · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes
Beth A Kozel · Geisinger Neuroscience Institute · funded by National Institutes of Health
2020–2025 · cooperative agreement · U18
Electronic Health Record-based Surveillance of Diabetes by Type in Young Adults in Pennsylvania
Annemarie Gregory Hirsch · Geisinger Neuroscience Institute · funded by Centers for Disease Control and Prevention
2020–2024 · cooperative agreement · U01
Feasibility and Assessment of a Cascade Traceback Screening program - FACTS
Nora B. Henrikson · Geisinger Neuroscience Institute · funded by National Institutes of Health
2020–2021 · research · R01
Consumer Protections for Genomics and Precision Health
Jennifer Kristin Wagner · Geisinger Neuroscience Institute · funded by National Institutes of Health
2020–2025 · career development · K01
Understanding the role of community determinants in opioid use disorder and program implementation factors influencing patient adherence to opioid agonist therapy
Melissa Poulsen · Geisinger Neuroscience Institute · funded by National Institutes of Health
2020–2025 · career development · K01
Understanding the role of community determinants in opioid use disorder and program implementation factors influencing patient adherence to opioid agonist therapy
Melissa Poulsen · Geisinger Neuroscience Institute · funded by National Institutes of Health
2020–2025 · career development · K01
Understanding the role of community determinants in opioid use disorder and program implementation factors influencing patient adherence to opioid agonist therapy
Melissa Poulsen · Geisinger Neuroscience Institute · funded by National Institutes of Health
2020–2025 · cooperative agreement · U18
Electronic Health Record-based Surveillance of Diabetes by Type in Young Adults in Pennsylvania
Annemarie Gregory Hirsch · Geisinger Neuroscience Institute · funded by Centers for Disease Control and Prevention
2020–2025 · career development · K01
Understanding the role of community determinants in opioid use disorder and program implementation factors influencing patient adherence to opioid agonist therapy
Melissa Poulsen · Geisinger Neuroscience Institute · funded by National Institutes of Health
2020–2026 · cooperative agreement · U01
Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes
Manfred Boehm · Geisinger Neuroscience Institute · funded by National Institutes of Health
2020–2024 · cooperative agreement · U01
Feasibility and Assessment of a Cascade Traceback Screening program - FACTS
Nora B. Henrikson · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2023 · research · R01
A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy
Christopher M Haggerty · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2026 · cooperative agreement · U01
Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders
David H. Ledbetter · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders
David H. Ledbetter · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2023 · research · R01
A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy
Christopher M Haggerty · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2024 · research · R01
A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy
Eric David Carruth · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2022 · research · R03
Geriatric Conditions and Treatment Burden in Older Adults with Non-Muscle-Invasive Bladder Cancer and Their Caregivers
Tullika Garg · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2028 · research · R01
Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH
Ana Morales Reyes · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2023 · research · R01
A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy
Christopher M Haggerty · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2023 · research · R01
Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH
Amy Curry Sturm · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2023 · research · R01
Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH
Amy Curry Sturm · Geisinger Neuroscience Institute · funded by National Institutes of Health
2019–2024 · cooperative agreement · U01
Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders
David H. Ledbetter · Geisinger Neuroscience Institute · funded by National Institutes of Health